Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Document › Details

Illumina, Inc.. (5/25/16). "Press Release: Illumina to Webcast Live Presentation at Upcoming Investment Conferences in June". San Diego, CA.

Organisations Organisation Illumina Inc. (Nasdaq: ILMN)
  Group Illumina (Group)
  Organisation 2 Goldman Sachs International
  Group Goldman Sachs (Group)
Products Product Goldman Sachs Annual Global Healthcare Conference 2016 Rancho Palos Verdes, CA
  Product 2 William Blair & Company Annual Growth Stock Conference 2016 Chicago
Index terms Index term Illumina–Goldman Sachs: investor conference, 201606 supply service Illumina presents at 37th Annual Global Healthcare Conference
  Index term 2 Illumina–William Blair: investor conference, 201606 supply service Illumina presents at William Blair Annual Growth Stock Conference in Chicago
Person Person Flatley, Jay T. (Illumina 200412 CEO)
     


Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at two upcoming investment conferences.

Illumina will webcast its presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 8, 2016. The live webcast is scheduled to begin at 9:20 AM PT and will feature a brief overview of the company by Jay Flatley, Chairman and CEO, followed by a question and answer session.

Illumina will also webcast its presentation at the William Blair & Company 2016 Growth Stock Conference in Chicago, Illinois, on June 15, 2016. The live webcast is scheduled to begin at 10:00 AM CT and will feature a brief overview of the company by Francis deSouza, President, followed by a question and answer session.

The webcasts can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.


About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.


Illumina, Inc.

Investors:
Rebecca Chambers
858-255-5243
ir@illumina.com
or
Media:
Jennifer Temple
858-882-6822
pr@illumina.com

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for Illumina (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top